Is cetirizine 10 mg safe to use during the eighth month of gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cetirizine 10 mg is Safe at 8 Months Gestation

Yes, cetirizine 10 mg is safe to use at 8 months gestation (third trimester), as second-generation antihistamines including cetirizine have accumulated substantial human safety data demonstrating no increased risk of congenital malformations or adverse fetal outcomes throughout pregnancy.

Evidence Supporting Safety

The most critical concern for medication-induced congenital malformations is during the first trimester when organogenesis occurs 1. At 8 months gestation, you are well past this critical window, making cetirizine use considerably safer from a teratogenic standpoint.

Guideline Recommendations

Second-generation antihistamines, including cetirizine, have been confirmed safe through large birth registries, case-control studies, and cohort studies 1. The 2008 practice parameter from the Journal of Allergy and Clinical Immunology explicitly states that sufficient human observational data has accumulated to demonstrate safety for second-generation antihistamines, with safety records comparable to first-generation agents 1.

Research Evidence Quality

Multiple high-quality studies support cetirizine safety:

  • A 2016 review identified cetirizine as one of the antihistamines of choice during pregnancy 2
  • A 2014 meta-analysis and cohort study found no clinically important increase in risk of adverse fetal outcomes with cetirizine 3
  • A 2008 prospective observational cohort study (n=196) showed no increased risk of major birth defects, spontaneous abortions, preterm deliveries, or birth weight differences 4
  • A 1997 prospective controlled study found no increased teratogenic risk with cetirizine 5

FDA Labeling Caveat

The FDA label states "if pregnant: ask a health professional before use" 6, which is standard cautionary language. However, this conservative labeling does not reflect the substantial accumulated safety data from clinical studies.

Clinical Considerations

At 8 months gestation, the primary concerns shift from teratogenicity to:

  • Maternal symptom control and quality of life
  • Avoiding medications that could affect labor or delivery
  • Neonatal effects immediately after birth

Cetirizine does not pose significant risks in any of these areas. The most common adverse effect is somnolence, which occurs more frequently than placebo but is generally well-tolerated 7.

Practical Recommendation

Use cetirizine 10 mg as needed for allergic symptoms at 8 months gestation. The standard adult dose of 10 mg daily is appropriate and well-studied 6. There is no need to avoid this medication or switch to alternatives at this stage of pregnancy, as the safety profile is well-established and the benefits of symptom control clearly outweigh any theoretical risks.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Allergy Medications During Pregnancy.

The American journal of the medical sciences, 2016

Research

The fetal safety of cetirizine: an observational cohort study and meta-analysis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2014

Research

Prospective controlled study of hydroxyzine and cetirizine in pregnancy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.